Physician profile
Mark Anthony Eid
NPI 1326570417
$3,392.33
in general payments reported to CMS, 2019-2025
10 companies · $2,023 in 2025
The $2,023 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.57 · 2023: $342 · 2024: $1,003 · 2025: $2,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,895 · Education: $1,103 · Grant: $320 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,895.28 |
| Education | $1,102.98 |
| Grant | $319.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,291.32 | 2023-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Cook Medical LLC | $721.53 | 2023-2025 | Zenith Spiral-Z, Zilver Ptx, Zenith |
| Medtronic, INC. | $563.67 | 2025 | |
| Abbott Laboratories | $399.43 | 2025 | Xact |
| Penumbra, INC. | $124.26 | 2025 | Indigo System |
| Bolton Medical INC | $122.90 | 2024 | Treo Abdominal Stent-Graft System |
| Endologix LLC | $71.44 | 2023 | Alto Abdominal Stent Graft System |
| Becton, Dickinson and Company | $50.00 | 2023 | Bd Safetyglide |
| Allergan, INC. | $24.57 | 2021 | |
| Boston Scientific Corporation | $23.21 | 2024 | Embold Fibered |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Eid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.